B+
Bull case
25%
Probability
Target price
$180.00
Analysis reference price unavailable
Analysis 2026-09-10 · RankAlpha Sentiment Codex
PODD
InsuletCNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
Q2 revenue reached $801.7 million, up 23.5% and above the high end of company guidance; adjusted operating income grew with 140 bps of margin expansion, and adjusted EPS rose 41.5%. The Omnipod platform, international growth, sensor compatibility, and next-generation automation pipeline support durable growth.
Posture
Mixed
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.4.
What can break
GAAP operating margin declined 250 bps year over year; adjusted margin expansion may not fully offset underlying cost or mix pressure.
Momentum
24
Value
56
Sentiment
50
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $160.00 · Bull $180.00 · Bear $115.00Analysis 2026-09-10; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-10 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-23
Investment thesis
As of 2026-10-23
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $165.00
Why
Momentum24 · Δ7d +11.4
Value56 · Δ7d -0.4
Sentiment50 · Δ7d -6.3
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta -0.4.
Contradictions & invalidation
- • GAAP operating margin declined 250 bps year over year; adjusted margin expansion may not fully offset underlying cost or mix pressure.
- • Medical-device competition, sensor ecosystem dependence, reimbursement conditions, and regulatory requirements could limit adoption.
- • Management reduced FY2026 total revenue-growth guidance to 20%-22% from 21%-23% previously and U.S.
Catalyst clock
2026-12-09
Q3 2026 guidance execution check
Lead driver: Value · See fundamentals
Momentum
24
8% active weight
Current posture
7d trendImproving
Δ7d
+11.4
Δ21d
+18.1
Value
56
47% active weight
Current posture
7d trendFlat
Δ7d
-0.4
Δ21d
-1.4
Sentiment
50
45% active weight
Current posture
7d trendSoftening
Δ7d
-6.3
Δ21d
-24.1
Why this grade
Composite grade C. Momentum 24.2 / Value 56.0 / Sentiment 50.0
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-10. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$160.00
Analysis reference price unavailable
Analysis 2026-09-10 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$115.00
Analysis reference price unavailable
Analysis 2026-09-10 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-23
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$10.33B
Beta
1.41
Shares Out
69.35M
P/E (TTM)
82.3
P/S (TTM)
7.91
P/FCF (TTM)
48.92
Rev YoY
+23.5%
EPS YoY
+234.8%
Gross Margin
+72.2%
Op Margin
+16.9%
Net Debt
$285.8M
Current Ratio
2.45
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data